[Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Oxaliplatin with 5-fluorouracil plus leucovorin (FOLFOX) has become the standard treatment in patients with colorectal cancer. Among known toxicities induced by oxaliplatin, hematological, gastrointestinal and neurological toxicities are common. However, acute pulmonary toxicity associated with oxaliplatin is unusual. One case of interstitial lung disease associated with the FOLFOX protocol is reported here.

Cite

CITATION STYLE

APA

Park, S., Jung, J. J., Kim, G. B., Yoon, H. S., Ko, S. H., Ko, J. E., & Lee, Y. S. (2010). [Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin]. The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi, 55(5), 340–343. https://doi.org/10.4166/kjg.2010.55.5.340

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free